CD274 and hepatocellular carcinoma: As expected, the post-TACE serum LAG-3 level was significantly decreased in responsive HCC patients compared to nonresponsive patients (P = 0.020), whereas the post-TACE serum PD-L1 level did not significantly change (P = 0.520).